University of Maryland - College Park, MD - 8/75 - 12/79 Bachelor of Science (Zoology)
Georgetown University School of Medicine - 3800 Resevoir Road, Washington, D.C. -20007 - 8/82 -5/87 -M.D. in Medicine
Dr. Doris Strader is a Professor of Medicine at the University of Vermont College of Medicine. While functioning as the Assistant Chief of Gastroenterology and the Chief of Hepatology at the Washington D.C. Veterans Affairs Medical Center, Dr. Strader honed her interest in hepatology by co-directing a large Liver Clinic and participating in clinical treatment trials of Hepatitis C. She has authored a number of publications and chapters, including articles on the natural history of Hepatitis C, drug-induced Hepatitis and the use of Complementary and Alternative medicines in Liver Disease. Most recently, she co-authored the `Guidelines for the Management of HCV' for the American Association for the Study of Liver Diseases. She participated in the NIH Consensus Conference on HCV Management, and has been asked to speak at many national meetings on topics relating to Hepatology. Dr. Strader is a member of the FDA Advisory Committee for Anti-Viral Drugs, and has been involved in the approval process for seven recent anti-viral medications for the treatment of HCV and HIV. She currently runs a Liver Clinic at The University of Vermont Medical Center and is Co-Investigator in treatment trials of HCV and NASH.
Dr. Strader's disease interests include:
The Relationship of CD81 Polymorphism to Clinical Disease in African-American an Caucasian Patients with Hepatitis C Virus Infection. Kerr GS, Martin MP, Strader DB, Carrington MN. 2/99 – present.
The Use of Complementary medicines in Liver Disease clinics in the U.S. Strader DB, Hoofnagle J, Bacon B, Lindsay K, LaBrecque D, Morgan T, Wright E, Allen J, Seeff LB.; 5/99 - 8/99.
Early Detection of Esophageal cancer/dysplasia in a high-risk population via Chromoendocscopy. Strader DB, Fleischer DE, Dawsey S, Eisen G, Lipman TO, Agarwal M, Wadleigh R.; 3/96 to present.
The Use of Rebetron in the Treatment of HIV/HCV Coinfected Patients. Benator D, Gibert C, Strader DB, Sharma A.; 6/99 – 10/01.
The Use of Rebetron for the Treatment of Naïve Patients with Hepatitis C – Dose Finding Study. Seeff LB, Strader DB (Schering-Plough coop study); 9/97 - 3/98.
The Use of Interferon/ Ribavirin in Patients with Hepatitis C who Relapsed on previous Interferon-Alone. Seeff LB, Strader DB, Sharma A.(Schering-Plough coop study); 3/97 – 11/99.
The Use of Alpha-Interferon in the treatment of Patients with Hepatitis C. Seeff LB, Strader DB (Schering-Plough coop study); approximately 1/95 – 6/97.
A Study of Lamivudine or Placebo in Patients with Chronic Hepatitis B Infection who are Treatment Naïve. Seeff LB, Strader DB (Glaxo-Sponsored study); 4/95-6/98
A Two-Stage Phase II Safety and Efficacy Study of IntraDose TM (Cisplatin/Epinephrine) Injectable Gel (MPI5010) Administered to Patients with Unresectable Primary Hepatocellular Carcinoma. Strader DB, Adib H, Seeff LB (Matrix-sponsored coop study); 9/96 – 9/97.
A Multicenter Trial to Evaluate the Epidemiology, Natural History and Treatment Response of Hepatitis C in the United States Veteran Population. Wright TL, Jeffers L, Rossi S. (Schering-Plough sponsored); 9/99 – 11/01.
Georgetown University School of Medicine
Assistant Professor of Medicine 3800 Resevoir Road, Washington, D.C. 20007 - 7/94 – present
Understudied Populations. NIH Consensus Conference on the Management of Hepatitis C. Hepatology Nov 2000;36(5)suppl 1:S226-S236
The Use of Complementary medicines in Liver Disease clinics in the U.S. Strader DB, Hoofnagle J, Bacon B, Lindsay K, LaBrecque D, Morgan T, Wright E, Allen J, Seeff LB. American Journal of Gastroenterology Sept 2002;97(9):2391-2398.High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function. Rao MN, Lui Q-H, Marmillot P, Seeff LB, Strader DB, Lakshman MR. Metabolism 2000;49(11):1406-1410.
Complementary and Alternative Medicine in Hepatitis C. Strader DB, Zimmerman HJ. In: Liang, TJ and Hoofnagle JH, eds. Hepatitis C. New York: Academic Press, 2000:427-451.Drug-Induced Chronic Liver Disease. Strader DB, Seeff LB. Clinics in Liver Disease 1998;Aug;2(3):501-522.